Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Taro Pharmaceutical Industries Ltd. reported that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for cetirizine hydrochloride tablets (OTC), 5 mg and 10 mg ("Cetirizine Tablets"). The product will be marketed by Taro's U.S. affiliate, Taro Pharmaceuticals U.S.A., Inc.


Today in Drug/Product Alerts...keeping you current

Watson Receives FDA Approval for Generic Cardizem(R) LA
Watson Pharmaceuticals, 03/16/10

Watson Announces Actos(R) Patent Challenge Settlement
Watson Pharmaceuticals, 03/11/10

Watson Confirms Filing of Generic Opana(R) ER Application
Watson Pharmaceuticals, 03/09/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address